June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
June 23, 2022
The University of Cincinnati's Xiaoting Zhang reviewed a new study for Medical News Today that found certain parabens may increase breast cancer risk for Black women.
June 14, 2022
The University of Cincinnati's Jordan Kharofa, MD, delivered a poster presentation at the American Society of Clinical Oncology annual meeting on new research on how diet and the microbiome affects young colorectal cancer patients.
June 13, 2022
University of Cincinnati professors and radiologists Ann Brown and Mary Mahoney joined patient advocate Michele Young and state legislators to celebrate the passage of House Bill 371, a bill that will require insurance companies to cover additional breast cancer screenings.
June 10, 2022
Healio highlighted clinical trial data presented by University of Cincinnati professor and Cincinnati Children's Hospital Medical Center oncologist Robin Norris on a new combination treatment for young patients with advanced-stage Hodgkin lymphoma.
June 10, 2022
The University of Cincinnati's Pier Paolo Scaglioni, MD, has received a $1.5 million National Cancer Institute grant to continue research into the roles of the KRAS gene and lipids in lung cancer.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
June 6, 2022
The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.
June 4, 2022
The University of Cincinnati's Thomas Herzog, MD, is presenting a poster describing a new immunotherapy trial for platinum-resistant ovarian cancer, called ARTISTRY-7, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
April 20, 2022
Nearly 10 years after a personal loss from a head and neck cancer, the Brandon C. Gromada Head & Neck Cancer Foundation continues to advance research around the devastating disease at the University of Cincinnati Cancer Center.
April 18, 2022
Yahoo! News featured University of Cincinnati research into the use of Optune devices that provide electrical field treatment to the brain as a treatment for glioblastomas.
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.